[PubMed] [Google Scholar] 125.Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadopoulos N., et al
Common examples include: Insulin Biologic medications Some anticoagulants GLP-1 medications Administration may also be reported using: CPT 96372 Documentation should clearly identify the route as subcutaneous rather than intramuscular
Further, some people may have difficulty accessing Wegovy if Part D plans apply prior authorization and step therapy tools to manage costs and ensure appropriate use
This unique administration requirement is due to the inclusion of an absorption enhancer (salcaprozate sodium) in the formulation, which facilitates semaglutide absorption across the gastric mucosa
Colonna-Romano G, Buffa S, Bulati M, Candore G, Lio D, Pellicano M, et al
Avoid freezing, repeated warming, or leaving the vial at room temperature for long periods, as these can reduce peptide stability